Login / Signup

Vonoprazan and high-dose amoxicillin dual therapy for Helicobacter pylori first-line eradication: A single-arm, interventional study.

Soichiro SueMasaaki KondoTakeshi SatoHiroyuki OkaKatsuyuki SangaTsuyoshi OgashiwaMao MatsubayashiHiroaki KanekoKuniyasu IrieShin Maeda
Published in: JGH open : an open access journal of gastroenterology and hepatology (2022)
Vonoprazan/high-dose amoxicillin dual therapy can be a safe standard first-line therapy. We are now undergoing a randomized controlled trial comparing dual therapy and vonoprazan-based triple therapy.
Keyphrases
  • helicobacter pylori
  • high dose
  • helicobacter pylori infection
  • low dose
  • mesenchymal stem cells
  • endoscopic submucosal dissection
  • cell therapy
  • bone marrow
  • gastroesophageal reflux disease
  • replacement therapy